{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:42:32Z","timestamp":1794055352750,"version":"4.8.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:00:00Z","timestamp":1549843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12876-019-0951-y","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T08:04:14Z","timestamp":1549872254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis"],"prefix":"10.1186","volume":"19","author":[{"given":"Michael","family":"Estep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Bratthauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Alaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinan","family":"Abdelatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Younoszai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary D.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zobair M.","family":"Younossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,11]]},"reference":[{"key":"951_CR1","doi-asserted-by":"publisher","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology [Internet]. 2018 1 [cited 2018 Feb 7];67(1):328\u201357. Available from: \n                    https:\/\/doi.org\/10.1002\/hep.29367\/abstract\n                    \n                  .","DOI":"10.1002\/hep.29367\/abstract"},{"key":"951_CR2","unstructured":"Younossi ZM, Loomba R, Anstee QM, Rinella ME, Bugianesi E, Marchesini G, et al. Diagnostic modalities for non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and associated fibrosis. Hepatol Baltim Md. 2017."},{"issue":"2","key":"951_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.5604\/16652681.1231550","volume":"16","author":"S Caldwell","year":"2017","unstructured":"Caldwell S, Lackner C. Perspectives on NASH histology: cellular ballooning. Ann Hepatol. 2017 Apr;16(2):182\u20134.","journal-title":"Ann Hepatol"},{"key":"951_CR4","doi-asserted-by":"publisher","unstructured":"Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, et al. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality. Hepatology [Internet]. 2011 [cited 2014 13];53(6):1874\u20131882. Available from: \n                    https:\/\/doi.org\/10.1002\/hep.24268\/abstract\n                    \n                  .","DOI":"10.1002\/hep.24268\/abstract"},{"key":"951_CR5","doi-asserted-by":"crossref","unstructured":"Jung ES, Lee K, Yu E, Kang YK, Cho M-Y, Kim JM, et al. Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease. J Pathol Transl Med [Internet]. 2016 May [cited 2017 Dec 13];50(3):190\u20136. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4876083\/\n                    \n                  .","DOI":"10.4132\/jptm.2016.03.01"},{"issue":"6","key":"951_CR6","first-page":"560","volume":"11","author":"ZM Younossi","year":"1998","unstructured":"Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol Off J U S Can Acad Pathol Inc. 1998;11(6):560\u20135.","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"2","key":"951_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.hepres.2005.09.018","volume":"33","author":"T Fukusato","year":"2005","unstructured":"Fukusato T, Fukushima J, Shiga J, Takahashi Y, Nakano T, Maeyama S, et al. Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis. Hepatol Res Off J Jpn Soc Hepatol. 2005;33(2):122\u20137.","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"issue":"4","key":"951_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","volume":"53","author":"S Caldwell","year":"2010","unstructured":"Caldwell S, Ikura Y, Dias D, Isomoto K, Yabu A, Moskaluk C, et al. Hepatocellular ballooning in NASH. J Hepatol. 2010 Oct;53(4):719\u201323.","journal-title":"J Hepatol"},{"issue":"5","key":"951_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jhep.2008.01.026","volume":"48","author":"C Lackner","year":"2008","unstructured":"Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol. 2008 May;48(5):821\u20138.","journal-title":"J Hepatol"},{"key":"951_CR10","doi-asserted-by":"crossref","unstructured":"Yeh MM, Brunt EM. Pathology of Nonalcoholic Fatty Liver Disease. Am J Clin Pathol [Internet]. 2007 1 [cited 2017 Dec 13];128(5):837\u201347. Available from: \n                    https:\/\/academic.oup.com\/ajcp\/article\/128\/5\/837\/1760386\n                    \n                  .","DOI":"10.1309\/RTPM1PY6YGBL2G2R"},{"key":"951_CR11","unstructured":"Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, et al. Current and future therapeutic regimens for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Hepatol Baltim Md. 2017 Dec;9."},{"key":"951_CR12","doi-asserted-by":"crossref","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015 149(2):389\u2013397.e10.","DOI":"10.1053\/j.gastro.2015.04.043"},{"issue":"5","key":"951_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, Fredrikson M, St\u00e5l P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatol Baltim Md. 2015;61(5):1547\u201354.","journal-title":"Hepatol Baltim Md."},{"key":"951_CR14","doi-asserted-by":"publisher","unstructured":"Younossi ZM, Stepanova M, Rafiq N, Henry L, Loomba R, Makhlouf H, et al. Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease. Hepatol Commun [Internet]. 2017 1 [cited 2017 Dec 13];1(5):421\u20138. Available from: \n                    https:\/\/doi.org\/10.1002\/hep4.1054\/abstract\n                    \n                  .","DOI":"10.1002\/hep4.1054\/abstract"},{"key":"951_CR15","doi-asserted-by":"crossref","unstructured":"Gramlich T, Kleiner DE, McCullough AJ, Matteoni CA, Boparai N, Younossi ZM. Pathologic features associated with fibrosis in nonalcoholic fatty liver disease. Hum Pathol [Internet]. 2004 1 [cited 2017 Dec 13];35(2):196\u20139. Available from: \n                    http:\/\/www.humanpathol.com\/article\/S0046-8177(03)00609-9\/fulltext\n                    \n                  .","DOI":"10.1016\/j.humpath.2003.09.018"},{"issue":"6","key":"951_CR16","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/hep.25559","volume":"55","author":"CD Guy","year":"2012","unstructured":"Guy CD, Suzuki A, Zdanowicz M, Abdelmalek MF, Burchette J, Unalp A, et al. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatol Baltim Md. 2012;55(6):1711\u201321.","journal-title":"Hepatol Baltim Md."},{"issue":"1","key":"951_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.21223","volume":"44","author":"A Wieckowska","year":"2006","unstructured":"Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatol Baltim Md. 2006;44(1):27\u201333.","journal-title":"Hepatol Baltim Md"},{"key":"951_CR18","doi-asserted-by":"publisher","unstructured":"Shen J, Chan HL-Y, Wong GL-H, Chan AW-H, Choi PC-L, Chan H-Y, et al. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers. Aliment Pharmacol Ther [Internet]. 2012 1 [cited 2018 Feb 9];36(11\u201312):1057\u201366. Available from: \n                    https:\/\/doi.org\/10.1111\/apt.12091\/abstract\n                    \n                  .","DOI":"10.1111\/apt.12091\/abstract"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-019-0951-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-019-0951-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T19:12:54Z","timestamp":1581361974000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-019-0951-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["951"],"URL":"https:\/\/doi.org\/10.1186\/s12876-019-0951-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,11]]},"assertion":[{"value":"21 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by Internal Review Board of Inova Fairfax Hospital (Federal Assurance FWA00000573). Sample collection and storage was approved by Inova IRB #05.047. Written informed consent for sample collection and use of samples for research at the Betty and Guy Beatty Center for Integrated Research, Inova Fairfax Medical Campus facility was obtained from all patients included in this study. The samples were de-identified in compliance with HIPAA regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"27"}}